Pediatric diabetes study with stem cells approved
Uppsala University Hospital and the principal investigator, Professor Per-Ola Carlsson, have been granted approval from the Medical Products Agency and the Swedish Ethical Review Authority to conduct a clinical drug trial with ProTrans™ to treat children and adolescents with type-1 diabetes. The study is a phase I / II study with a total of 66 patients.
Stem cells in study against type 1 diabetes in children
“The results of this cell therapy are very promising and it has now been shown to be effective in type 1 diabetes in a randomized, placebo-controlled study in adults. We hope to see the same positive effect in children”, says Per-Ola Carlsson, Chief Physician and Professor at Uppsala University Hospital / Uppsala University